Description of a tall-man lettering program for look-alike and sound-alike antineoplastic agents

Authors:

Abstract
Tall-man (i.e., mixed-case) lettering is used to highlight dissimilarities in look-alike and sound-alike (LASA) drug names.1 Studies have shown that emphasizing definitive sections of drug names using capitalized letters can help distinguish between similar looking and sounding medications (e.g., vinBLAStine, vinCRIStine), making them less prone to mistake for one another and thereby reducing medication errors.2,3 Despite the benefits of tall-man lettering and its endorsement by the Institute for Safe Medication Practices, Food and Drug Administration, Joint Commission, and National Association of Boards of Pharmacy, there is a lack of definitive standard guidance regarding its use.